A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer.
Tzenaki N, Xenou L, Goulielmaki E, Tsapara A, Voudouri I, Antoniou A, Valianatos G, Tzardi M, De Bree E, Berdiaki A, Makrigiannakis A, Papakonstanti EA.
Tzenaki N, et al. Among authors: papakonstanti ea.
Commun Biol. 2024 Jan 5;7(1):26. doi: 10.1038/s42003-023-05639-8.
Commun Biol. 2024.
PMID: 38182748
Free PMC article.